Roche Canada and pCPA conclude talks for Vabysmo eye therapy
Pharmaceutical Technology
MAY 30, 2023
Canada’s health technology assessment bodies, including the Canadian agency for drugs and technologies in health (CADTH) and the institut national d’excellence en santé et en services sociaux (INESSS) have both reviewed Vabysmo and recommended it to treat nAMD and DME.
Let's personalize your content